Lindbrook Capital’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.92K Buy
39
+13
+50% +$1.21K ﹤0.01% 2160
2024
Q4
$2.66K Hold
26
﹤0.01% 2218
2024
Q3
$2.74K Sell
26
-24
-48% -$2.45K ﹤0.01% 2248
2024
Q2
$4.66K Buy
50
+24
+92% +$2.54K ﹤0.01% 2034
2024
Q1
$3.39K Hold
26
﹤0.01% 2060
2023
Q4
$2.95K Buy
26
+13
+100% +$1.13K ﹤0.01% 2123
2023
Q3
$1.07K Sell
13
-11
-46% -$966 ﹤0.01% 2338
2023
Q2
$2.25K Sell
24
-1
-4% -$80 ﹤0.01% 2110
2023
Q1
$1.7K Buy
+25
New +$2.02K ﹤0.01% 2310

Other funds holding BXC

Lindbrook Capital's BXC Position: Q1 2025 in Review

Lindbrook Capital increased its BlueLinx (BXC) stake by 50% in Q1 2025, buying an estimated $1.21K and bringing the position to 39 shares worth $2.92K. The position accounts for ﹤0.01% of the portfolio, ranked #2160.

Lindbrook Capital first reported a position in BXC in Q1 2023 and has held it in 9 quarters since. The position peaked at $4.66K in Q2 2024. 161 funds tracked by Wall St. Rank hold BXC as of Q1 2025.

  • Lindbrook Capital held 39 shares of BlueLinx worth $2.92K as of Q1 2025.
  • Lindbrook Capital bought 13 BlueLinx shares in Q1 2025, an estimated $1.21K.
  • BlueLinx made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2160 holding.
  • Lindbrook Capital first reported a position in BlueLinx in Q1 2023 and has held it in 9 quarters since.
  • Lindbrook Capital's BlueLinx position peaked at $4.66K in Q2 2024.
  • 161 funds tracked by Wall St. Rank held BlueLinx as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.